Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms.
Yang KC, Kalloger SE, Aird JJ, Lee MKC, Rushton C, Mungall KL, Mungall AJ, Gao D, Chow C, Xu J, Karasinska JM, Colborne S, Jones SJM, Schrader J, Morin RD, Loree JM, Marra MA, Renouf DJ, Morin GB, Schaeffer DF, Gorski SM. Yang KC, et al. Among authors: schrader j. Cell Rep. 2021 Oct 12;37(2):109817. doi: 10.1016/j.celrep.2021.109817. Cell Rep. 2021. PMID: 34644566 Free article.
Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model.
Benten D, Behrang Y, Unrau L, Weissmann V, Wolters-Eisfeld G, Burdak-Rothkamm S, Stahl FR, Anlauf M, Grabowski P, Möbs M, Dieckhoff J, Sipos B, Fahl M, Eggers C, Perez D, Bockhorn M, Izbicki JR, Lohse AW, Schrader J. Benten D, et al. Among authors: schrader j. Mol Cancer Res. 2018 Mar;16(3):496-507. doi: 10.1158/1541-7786.MCR-17-0163. Epub 2018 Jan 12. Mol Cancer Res. 2018. PMID: 29330294
Targeting HDACs in Pancreatic Neuroendocrine Tumor Models.
Schmitz RL, Weissbach J, Kleilein J, Bell J, Hüttelmaier S, Viol F, Clauditz T, Grabowski P, Laumen H, Rosendahl J, Michl P, Schrader J, Krug S. Schmitz RL, et al. Among authors: schrader j. Cells. 2021 Jun 6;10(6):1408. doi: 10.3390/cells10061408. Cells. 2021. PMID: 34204116 Free PMC article.
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
Fraune C, Simon R, Hube-Magg C, Makrypidi-Fraune G, Kluth M, Büscheck F, Amin T, Viol F, Fehrle W, Dum D, Höflmayer D, Burandt E, Clauditz TS, Perez D, Izbicki J, Wilczak W, Sauter G, Steurer S, Schrader J. Fraune C, et al. Among authors: schrader j. Endocr Pathol. 2020 Jun;31(2):182-189. doi: 10.1007/s12022-020-09612-7. Endocr Pathol. 2020. PMID: 32144630 Free PMC article.
Multicenter Analysis of Presacral Neuroendocrine Neoplasms-Clinicopathological Characterization and Treatment Outcomes of a Rare Disease.
Matrood S, Apostolidis L, Schrader J, Krug S, Lahner H, Ramaswamy A, Librizzi D, Kender Z, Kröcher A, Kreutzfeldt S, Gress TM, Rinke A. Matrood S, et al. Among authors: schrader j. Front Endocrinol (Lausanne). 2021 Oct 6;12:709256. doi: 10.3389/fendo.2021.709256. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34690926 Free PMC article.
EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs).
April-Monn SL, Andreasi V, Schiavo Lena M, Sadowski MC, Kim-Fuchs C, Buri MC, Ketkar A, Maire R, Di Domenico A, Schrader J, Muffatti F, Doglioni C, Partelli S, Falconi M, Perren A, Marinoni I. April-Monn SL, et al. Among authors: schrader j. Cancers (Basel). 2021 Oct 7;13(19):5014. doi: 10.3390/cancers13195014. Cancers (Basel). 2021. PMID: 34638497 Free PMC article.
917 results